Code Bio: Code Biotherapeutics' $75 Million Series A Financing
Morrison Foerster advised New Enterprise Associates, 4BIO Capital, and UPMC Enterprises on the deal. New Enterprise Associates, 4BIO Capital, and UPMC Enterprises acted as investors in [...]
Read full article »
Code Bio is a Pennsylvania-based biotechnology company that develops and commercializes non-viral gene therapies for the treatment of rare diseases.
Read more